INTERLEUKIN-2 THERAPY AND BLOCKAGE OF DOUBLE-LUMEN CATHETERS

R. J. M. Strack van Schijndel(Van Andel Institute), John Wagstaff(Maastricht University Medical Centre), H. J. Voerman, R.P. Golding(University of Amsterdam)

The Lancet

April 1, 1989

10.1016/s0140-6736(89)92545-2

Cited by 3

Related Papers

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

|The Lancet|2015|2k

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

|New England Journal of Medicine|2017|1.8k

Optimal Protein and Energy Nutrition Decreases Mortality in Mechanically Ventilated, Critically Ill Patients

|Journal of Parenteral and Enteral Nutrition|2011|421

Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: A randomized study*

|Critical Care Medicine|2006|373

Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit

|Critical Care Medicine|1990|368